Health news
Sandoz is voluntarily recalling 13 lots of Orphenadrine Citrate 100mg extended-release (ER) tablets to the consumer level due to the presence of a nitrosamine impurity, NMOA or nitroso-orphenadrine, above the Food and Drug Administration’s (FDA)…
The Food and Drug Administration (FDA) has approved the Evoke® Spinal Cord Stimulation (SCS) System for the treatment of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed…
Soin Therapeutics has been granted the Food and Drug Administration (FDA)’s Orphan Drug designation for the use of low dose naltrexone in the treatment of complex regional pain syndrome (CRPS). According to the Company, anecdotal…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021